Suppressor of cytokine signaling (SOCS)-1 is an inhibitory molecule for JAK, and its de®ciency in mice leads to lymphocyte-dependent multi-organ disease and perinatal death. Crossing of SOCS-1 ±/± mice on an IFN-g ±/± , STAT1 ±/± and STAT6 ±/± background revealed that the fatal disease of SOCS-1 ±/± mice is also dependent on IFN-g/STAT1 and IL-4/STAT6 signaling pathways. Since IFN-g and IL-4 are representative T h 1 and T h 2 cytokines respectively, here we investigated the role of SOCS-1 in T h differentiation. Freshly isolated SOCS-1 ±/± CD4 + T cells stimulated with anti-CD3 rapidly produced larger amounts of IFN-g and IL-4 than control cells, suggesting that these mutant T cells had already differentiated into T h 1 and T h 2 cells in vivo. In addition, SOCS-1 +/± CD4 + T cells cultured in vitro produced signi®cantly larger amounts of IFN-g and IL-4 than SOCS-1 +/+ cells. Similarly, SOCS-1 +/± CD4 + T cells produced more IFN-g and IL-4 than SOCS-1 +/+ cells after infection with Listeria monocytogenes and Nippostrongyrus braziliensis respectively. Since IL-12-induced STAT4 and IL-4-induced STAT6 activation is sustained in SOCS-1 ±/± T cells, the enhanced T h functions in SOCS-1 ±/± and SOCS-1 +/± mice appear to be due to the enhanced effects of these cytokines. These results suggest that SOCS-1 plays a regulatory role in both T h 1 and T h 2 polarizations.
Introduction

CD4 + T cells play a critical role in immune responses following microbial infection (1±3).
After stimulation with pathogens, these cells differentiate into two subsets known as T h 1 and T h 2 cells. These T h 1 and T h 2 cells are characterized by their pro®les of cytokine production such as IFN-g and IL-4 respectively. Commitment to T h 1 or T h 2 cells is essential for eradication of various pathogens and also plays a role in the induction of various diseases, including autoimmune diseases and allergy. Despite considerable efforts, the signals that induce the commitment of naive CD4 + T cells into T h 1 or T h 2 cells are still to be elucidated. However, many studies suggest that multiple factors in¯uence T h commitment at various stages.
Cytokines are profoundly involved in the process of CD4 + T cell differentiation (2, 3) . In particular, signals of IL-12 and IL-4 are relevant to T h 1 and T h 2 differentiation respectively. Recent characterization of suppressor of cytokine signaling (SOCS) / STAT-induced STAT inhibitor/cytokine-inducible SH2-containing protein (CIS) family proteins has revealed that cytokines are, at least in part, negatively regulated by the members of this family (4±6). Among these proteins, SOCS-1 appears to have the most broad inhibitory effect on cytokines including IL-4, IFN-g and possibly IL-12 in vitro, since SOCS-1 interacts with and inhibits all four members of JAK that play essential roles in the signaling by various cytokines.
Generation of SOCS-1 ±/± mice revealed the critical roles of SOCS-1 in vivo (7, 8) . Although SOCS-1 ±/± mice appear normal at birth, they exhibit growth retardation with aging and multiorgan in¯ammatory changes with mononuclear cell in®ltration, and die before 3 weeks of age (7, 8) .
Intriguingly, T cells isolated from SOCS-1 ±/± mice are endogenously activated (9, 10) and SOCS-1/Rag-2 double knockout (DKO) mice which lack mature lymphocytes are rescued from this fatal disease (10) . These SOCS-1 ±/± T cells appear to aberrantly produce IFN-g in vivo, since signi®cant elevation of serum IFN-g is observed in SOCS-1 ±/± mice (10) . In addition, IFN-g is critically involved in the disease of SOCS-1 ±/± mice since SOCS-1/ IFN-g DKO mice are also free from early death (11) . Recently, another study revealed a defect of SOCS-1 ±/± CD4 + T cells in IL-6-mediated inhibition of T h 1 differentiation (12) . Thus, previous studies have strongly linked SOCS-1 to the action of IFN-g, and suggest that SOCS-1 plays a critical role in the inhibition of IFN-g signaling and T h 1 response in vivo. More recently, however, we demonstrated that SOCS-1/STAT6 DKO mice and SOCS-1/STAT1 DKO mice, which are defective in IL-4 and IFN-g signaling respectively, survive much longer than SOCS-1 ±/± mice, and exhibit milder thymic and splenic atrophy with a remarkable reduction in numbers of activated T cells (9) . This ®nding appears to suggest that SOCS-1 ±/± mice are injured by endogenous accumulation not only of IFN-g, but also of IL-4.
In the present study, to precisely evaluate a role for SOCS-1 in the immune systems, we examined whether SOCS-1 levels in¯uence T h 1 and/or T h 2 differentiation. Freshly isolated SOCS-1 ±/± CD4 + T cells and cultured SOCS1 +/± CD4 + T cells produced larger amounts of both IL-4 and IFN-g than control cells. In addition, SOCS-1 +/± mice exhibited hyper-polarization into T h 1 and T h 2 phenotypes upon infection with Listeria monocytogenes and Nippostrongyrus braziliensis respectively. Collectively, our ®ndings suggest that SOCS-1 insuf®-ciency leads to the enhanced T h 1 and T h 2 responses, but not to selective polarization into T h 1 cells.
Methods
Mice
The generation of SOCS-1 ±/± , SOCS-1/STAT1 DKO and SOCS-1/STAT6 DKO mice was reported previously (8, 9) . SOCS-1 ±/± , SOCS-1 +/± and SOCS-1 +/+ mice used here were backcrossed more than seven generations on a C57BL/6 background, as reported previously (9) . All the SOCS-1 ±/± mice including DKO mice and their littermate controls were used at 2±3 weeks of age, while SOCS-1 +/± mice and their littermate controls were used at 6±12 weeks of age. Mice were kept in speci®c pathogen-free facilities.
Cell preparation
Single-cell suspensions were obtained from thymuses and spleens as described previously (13) . Where indicated, splenic CD4 + T cells were puri®ed using anti-CD4±FITC (PharMingen, San Diego, CA), anti-FITC beads and a magnetic cell sorter (MACS; Miltenyi Biotec, Gladbach, Germany) according to the manufacturer's instructions.
Flow cytometric analysis
Splenocytes were incubated with indicated antibodies and analyzed on a FACSCalibur (Becton Dickinson, San Jose, CA) using CellQuest software. The antibodies used were FITC-, phycoerythrin-, PerCP-and allophycocyanin-conjugated anti-CD4, -CD8, -B220 and -IgM (PharMingen).
Cell culture
Lymphocytes were cultured in RPMI 1640 supplemented with 10% FCS (JRH Biosciences, Lenexa, KS), 2-mercaptoethanol (Nacalai Tesque, Kyoto, Japan), penicillin G and streptomycin. Splenic CD4 + T cells were stimulated with plate-bound anti-CD3e plus anti-CD28 (1 mg/ml each; PharMingen) and culture supernatants were harvested daily for ELISA. For in vitro T h 1/T h 2 polarization, CD4 + T cells were stimulated with plate-bound anti-CD3e plus anti-CD28 (1 mg/ml) in the presence of murine IL-2 (10 ng/ml; PeproTech, London, UK). For T h 1 differentiation, murine IL-12 (10 ng/ml; PharMingen) and anti-IL-4 (10 mg/ml; PharMingen) were added to the culture media, and for T h 2 differentiation, murine IL-4 (10 ng/ml; PeproTech), anti-IL-12 and anti-IFN-g (10 mg/ml each; PharMingen) were added. After 4 days, these cells were harvested, washed and re-stimulated with plate-bound anti-CD3 plus anti-CD28 (1 mg/ml). After 24 h, culture supernatants were obtained for ELISA.
Intracellular cytokine staining
Naive CD4 + T cells (CD4 + CD62L hi cells) were enriched from spleens. In brief, CD4 + T cells were obtained from spleen cells using SpinSep Murine CD4 T cell (Stemcell Technologies, Vancouver, Canada) according to the manufacturer's instructions. These cells were then positively sorted with anti-CD62L beads and MACS systems (Miltenyi Biotec). Obtained cells were stimulated in vitro for 4 days in T h 1 or T h 2 conditions as described above and harvested 5 h after re-stimulation with plate-bound anti-CD3 (5 mg/ml) in the presence of Monensin (3 nM; Sigma, St Louis, MO) for the last 2.5 h. These cells were ®rst treated with CyChrome-labeled anti-CD4 (PharMingen) and then stained with the indicated anti-cytokine antibodies (PharMingen) using the Cyto®x/Cytoperm kit (PharMingen). Flow cytometric analysis was performed on a FACSCalibur. Results were shown for CD4 + live T cells determined by FSC and SSC pro®les.
Western blot analysis
Thymocytes were stimulated with concanavalin A (2 mg/ml; Sigma) for 3 days, harvested, washed 3 times with PBS, counted and re-stimulated with murine IL-12 (20 ng/ml; PharMingen) or murine IL-4 (20 ng/ml; PeproTech) for 20 min. After vigorous washing and incubation in culture media for indicated minutes, cells were lysed with ice-cold buffer containing 1% Nonidet P-40, 10 mM Tris±HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM Na 3 VO 4 and 10 ml/ ml aprotinin (Sigma). Western blotting was performed as described previously (14) . Mice with various genotypes were infected with 5 Q 10 5 L. monocytogenes through a tail vein or were inoculated s.c. with 400 N. braziliensis as shown previously (15) . At day 14, splenic CD4 T cells were prepared using MACS (Miltenyi Biotec) following incubation with anti-CD4 beads (Miltenyi Biotec) and activated with plate-bound anti-CD3e (PharMingen) for 48 h. Concentrations of IFN-g and IL-4 in each supernatant were determined by ELISA (Genzyme TECHNE, Boston, MA). In the case of N. braziliensis infection, serum was sampled at indicated time points for measurement IgE by ELISA (PharMingen).
Results
Improved phenotype of T cells in STAT1-or STAT6-depleted SOCS-1 ±/± mice
As we reported previously, both SOCS-1/STAT1 and SOCS-1/ STAT6 DKO mice exhibited signi®cant restoration from the hepatic disease caused by SOCS-1 de®ciency and survived longer than mice lacking SOCS-1 alone (9). In addition, as shown in Fig. 1 , the lymphocyte depletion observed in spleen of SOCS-1 ±/± mice was signi®cantly improved both in SOCS-1/ STAT1 and in SOCS-1/STAT6 DKO mice. These results indicate that IFN/STAT1 and IL-4/STAT6 signaling are both involved in the disease progression of SOCS-1 ±/± mice and affect the homeostasis of peripheral lymphocytes.
SOCS-1 ±/± CD4 + T cells spontaneously differentiate into T h 1 and T h 2 cells
Because IFN-g and IL-4 are hallmark cytokines generated by T h 1 and T h 2 cells respectively, the above results suggest that CD4 + T cells of SOCS-1 ±/± mice may spontaneously differentiate into T h 1 and T h 2 cells in vivo. Therefore, we next stimulated splenic CD4 + T cells from SOCS-1 ±/± or SOCS-1 +/± mice with plate-bound anti-CD3 for 24 h. CD4 + T cells prepared from SOCS-1 ±/± mice rapidly produced extremely large amounts of both IFN-g and IL-4 compared with those from control mice (Fig. 1B) . A similar result was obtained bȳ ow cytometric analysis with intracellular staining of IFN-g and IL-4 (data not shown). These results extend the previous ®ndings that SOCS-1 ±/± T cells are spontaneously activated (9, 10) , and suggest that these CD4 + T cells have already differentiated into T h 1 and T h 2 cells in vivo. Thus, although the stimuli that drive SOCS-1 ±/± CD4 + T cells to differentiate into T h 1/T h 2 cells are currently unknown, it is likely that SOCS-1 de®ciency leads to enhanced T h 1/T h 2 responses in vivo.
SOCS-1 levels affect production of both IL-4 and IFN-g after stimulation with anti-CD3/anti-CD28
Next, we used SOCS-1 +/± CD4 + T cells instead of SOCS-1 ±/± cells in vitro. This is because SOCS-1 +/± mice are healthy and contain normal numbers of naive CD4 + T cells which we failed to obtain suf®ciently from SOCS-1 ±/± mice due to accelerated apoptosis and spontaneous activation of SOCS-1 ±/± T cells (8) . Furthermore, it was reported that inactivation of a single SOCS-1 allele has biological effects suf®cient to restore the lactation defect in PRLR +/± mice (16) . We ®rst investigated the role of SOCS-1 in cytokine production by CD4 + T cells upon TCR engagement. SOCS-1 +/± CD4 + T cells as well as SOCS-1 +/+ control cells were stimulated with plate-bound anti-CD3 plus anti-CD28 and culture supernatants were harvested daily to examine the secretion of cytokines. As shown in Fig. 2(A) , similar amounts of IL-2 were produced both in SOCS-1 +/+ and SOCS-1 +/± CD4 + T cells, suggesting that the lack of a single SOCS-1 allele does not affect signaling of CD3/CD28 pathways. However, as shown in Fig. 2(B) , production of IFN-g was enhanced in SOCS-1 +/± mice. This result is consistent with those of previous studies demonstrating a role of SOCS-1 in the regulation of IFN-g secretion in vivo (10) and in vitro (12) . In addition, interestingly, production of IL-4 was also enhanced in SOCS-1 +/± CD4 + T cells (Fig. 2C) . These results indicate that SOCS-1 +/± CD4 + cells can be polarized more easily and/or rapidly than SOCS-1 +/+ CD4 + cells, and suggest a role for SOCS-1 in the negative regulation of both T h 1 and T h 2 responses.
SOCS-1 +/± CD4 + T cells have enhanced potential to develop into T h 1 and T h 2 cells in vitro
We next incubated these cells under neutral, T h 1-or T h 2-polarizing culture conditions in vitro. As shown in Fig. 3(A) , modestly elevated production of IFN-g under T h 1-polarizing conditions was observed in SOCS-1 +/± CD4 + T cells. In addition, IL-4 production under T h 2 polarizing conditions was also enhanced in SOCS-1 +/± CD4 + T cells (Fig. 3B) . It should be noted that IFN-g production under T h 2 conditions as well as IL-4 production under T h 1 conditions were not enhanced in SOCS-1 +/± cells. We also analyzed the status of T h polarization by another method. In this experiment, we used puri®ed naive CD4 + T cells, cultured these cells under T h 1-or T h 2-polarizing conditions and analyzed them by intracellular cytokine staining. As shown in Fig. 3(C) , enhanced T h polarization was observed again in SOCS-1 +/± CD4 + T cells. Compared with the result shown in Fig. 2 , the enhancement of IFN-g/IL-4 production by SOCS-1 +/± CD4 + T cells on these T h 1/ T h 2-polarizing conditions was less signi®cant. However, in repeated experiments, when SOCS-1 +/± CD4 + T cells were compared to SOCS-1 +/+ cells, IL-4 as well as IL-10 production under T h 2 conditions was always more marked than IFN-g production under T h 1 conditions. These results suggest again that SOCS-1 negatively regulates not only the process of T h 1 differentiation, but also that of T h 2 differentiation.
SOCS-1 levels in¯uence the intensity of both T h 1 and T h 2 polarization in vivo
The impact of SOCS-1 insuf®ciency on T h 1/T h 2 cell differentiation was further con®rmed by in vivo experiments. SOCS-1 +/ + and SOCS-1 +/± mice were infected with L. monocytogenes, an intracellular facultative Gram-positive bacterium which induces T h 1 responses in hosts. Fourteen days after infection, splenic CD4 + T cells were stimulated in vitro with immobilized anti-CD3 to evaluate the status of T h differentiation. Consistent with the data obtained in vitro, CD4 + T cells from SOCS-1 +/± mice produced larger amounts of IFN-g than those from SOCS-1 +/+ CD4 + T cells (Fig. 4A) , demonstrating the inhibitory effect of SOCS-1 in vivo on T h 1 differentiation. Next, SOCS-1 +/+ and SOCS-1 +/± mice were infected with N. braziliensis, a nematode which induces T h 2 cell differentiation in mice. SOCS-1 +/± CD4 + T cells again produced larger amounts of IL-4 than SOCS-1 +/+ CD4 + T cells (Fig. 4B) . In addition, enhanced T h 2 response after N. braziliensis infection was also mani- fested by the signi®cant elevation of serum IgE levels in SOCS-1 +/± mice (Fig. 4C) . These results indicate that T h 2 differentiation is also negatively regulated in vivo by SOCS-1.
SOCS-1 de®ciency leads to sustained STAT4 activation in response to IL-12
As has been reported previously, SOCS-1, at least in vitro, is capable of inhibiting a wide range of cytokines by suppressing JAK (4±6). To elucidate the molecular basis for the enhanced T h 1/T h 2 differentiation in SOCS-1 ±/± and SOCS-1 +/± mice, the duration of JAK/STAT activation in response to cytokines was examined using thymocytes from SOCS-1 +/+ and SOCS-1 ±/± mice. Consistent with the previous observation (9), IL-4-induced STAT6 phosphorylation was signi®cantly sustained in SOCS-1 ±/± T cells (Fig. 5) . In addition, IL-12-induced phosphorylation of STAT4 was also sustained in SOCS-1 ±/± T cells (Fig. 5) . Thus, enhanced T h 1/T h 2 responses of SOCS-1 ±/± mice can be ascribed, at least in part, to sustained signaling of cytokines such as IL-12 and IL-4.
Discussion
In this study, we ®rst showed that lymphocytes from SOCS-1/ STAT1 and SOCS-1/STAT6 DKO mice are both partially but signi®cantly rescued from the disease caused by SOCS-1 de®ciency. This result suggests that signaling pathways of both IFN/STAT1 and IL-4/STAT6 affect the homeostasis of lymphocytes in SOCS-1 ±/± mice. In addition, these cytokines appear to be produced by CD4 + T cells, since splenic CD4 + T cells from SOCS-1 ±/± mice rapidly secreted signi®cant amounts of IFN-g and IL-4 in response to anti-CD3 in vitro. Collectively, SOCS-1 ±/± CD4 + T cells, activated spontaneously by unknown stimuli in vivo, may differentiate not only into T h 1 cells but also into T h 2 cells.
Enhanced T h 1/T h 2 responses were also observed in SOCS-1 +/± CD4 + T cells. Interestingly, although freshly isolated SOCS-1 +/± CD4 + T cells showed normal expression of CD62L and CD69 (data not shown) and normal production of IL-2 in vitro ( Fig. 2A) , these cells rapidly acquired the ability to produce IFN-g and IL-4 in response to anti-CD3 and anti-CD28 stimulation. SOCS-1 +/± CD4 + T cells also produced larger amounts of IFN-g as well as IL-4 than SOCS-1 +/+ cells on T h 1 and T h 2 culture conditions respectively. In addition, SOCS-1 +/± mice challenged with L. monocytogenes and N. braziliensis in vivo exhibited enhanced T h 1 and T h 2 responses respectively. Thus, deletion of one SOCS-1 allele has some gene dosage effect and complete function of SOCS-1 is required for the proper regulation not only of T h 1 response, but also of T h 2 response. These ®ndings are also supported by recent analyses. The gene dosage effect of SOCS1 was previously demonstrated through the analysis of SOCS-1 +/± PRLR +/± mice (16) . Furthermore, the role of SOCS-1 in T h 2 regulation was suggested by the ®nding in in vitro cultures of various SOCS-1 ±/± organs with enhanced production of IL-5 (17) . Thus, SOCS-1 regulates the activation and differentiation of CD4 + T cells rather than the balance of T h 1/T h 2 responses.
The mice used by us and others were originally generated on a mixed genetic background of C57/BL6 and 129/Sv (7, 8, 10) , and the mice used here have been backcrossed further on a C57/BL6 background (9) . As is well known, these mice preferentially generate T h 1 responses rather than T h 2 responses. This may augment the production and toxicity of IFN-g in SOCS-1 ±/± mice. As shown here, however, SOCS-1 regulates not only T h 1 response, but also T h 2 response. It is therefore of interest to cross SOCS-1 ±/± mice on a T h 2-dominant background such as BALB/c and examine T h regulation in the absence of SOCS-1. Such mice may exhibit a T h 2-dominant allergic disease which is different from that on a C57/BL6 and/or 129 background. This project is currently underway in our laboratory.
The hyper-responsiveness of SOCS-1 ±/± and SOCS-1 +/± mice to T h 1/T h 2-inducing stimuli appears to be ascribed, at least in part, to the defect of these mice in the termination of several cytokine signaling. Consistent with our previous ®nding (8), we found that IL-4-induced STAT6 activation was prolonged in SOCS-1 ±/± T cells. This result suggests that the effect of IL-4, the most critical cytokine in T h 2 responses, is enhanced in the absence of SOCS-1. On the other hand, we and others have shown previously that IFN-g-induced STAT1 activation is sustained in SOCS-1 ±/± cells (9, 18) . In addition, we showed here that IL-12-induced STAT4 activation was also prolonged in SOCS-1 ±/± T cells. These ®ndings suggest that the effects of IL-12, the most critical cytokine in T h 1 responses, as well as those of IFN-g, a cytokine that is also involved in T h 1 responses, are enhanced in the absence of SOCS-1. Thus, SOCS-1 insuf®ciency may lower the threshold for cytokineinduced activation/differentiation of CD4 + T cells, may lead to enhanced response to endogenous as well as exogenous cytokines and may ®nally result in enhanced effector functions of CD4 + T cells. The broad inhibitory action of SOCS-1 on cytokines including IL-4 and IL-12 is also consistent with the results of a recent analysis of transgenic mice that overexpress the dominant-negative form of SOCS-1 (19) . In this context, we cannot rule out the possibility that cytokines other than IL-4, IFN-g and IL-12 may also be involved in the enhanced responses of SOCS-1 ±/± T cells.
While previous analyses of T h 1/T h 2 regulation focused mainly on the molecules that promote T h differentiation, several molecules that negatively regulate T h differentiation were also reported. These include Bcl-6 (20), NFATp(NFAT1)/ NFAT4 (21), CTLA-4 (22) and DR6 (23) . Interestingly, these molecules appear to limit T h 2 differentiation and mice lacking these factors except for DR6 exhibit T h 2-dominant fatal lymphoproliferative diseases. It is of note that mice lacking SOCS-1, as reported repeatedly, exhibit a fatal disease with the in®ltration of mononuclear cells in several organs. However, SOCS-1 differs from the negative regulators described above, since it appears to inhibit both T h 1 and T h 2 differentiation. In either case, these results show that the process of T h differentiation must be critically regulated at multiple steps to prevent fatal organ injuries due to overactivation of effector T cells.
Since complete lack of SOCS-1 resulted in early lethality in mice, it appears unlikely that genetic alteration of SOCS-1 which completely eliminates its action leads to some hereditary disease in humans. However, previous studies have revealed the involvement of SOCS-1 functions in human diseases. These studies demonstrated that insuf®cient induction of SOCS-1 mRNA due to the methylation of CpG islands of SOCS-1 promoter correlates with the occurrence and/or progression of hepatocellular carcinoma (HCC) (24, 25) . Because the lack of one SOCS-1 allele is suf®cient to cause hyper-responsiveness to T h -inducing stimuli, reduced induction of SOCS-1 in lymphocytes as in HCC cells or genetic mutation resulting in a partial loss of SOCS-1 function and/or induction may enhance the responses to pathogens, which may result in their rapid clearance or, in some cases, enhanced tissue injuries by hyper-activated immune systems. It is also conceivable that these conditions may promote the progression of T h 1/T h 2-related diseases such as multiple sclerosis and bronchial asthma. Thus, SOCS-1 is a candidate gene that in¯uences the individual susceptibility to infections and several immune disorders. Future studies are required to fully elucidate the relevance of SOCS-1 to human diseases.
